Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Psoriatic Arthritis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriatic Arthritis Drugsmarket, defines the market attractiveness level of Psoriatic Arthritis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Psoriatic Arthritis Drugs industry, describes the types of Psoriatic Arthritis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriatic Arthritis Drugs market and the development prospects and opportunities of Psoriatic Arthritis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriatic Arthritis Drugs market in Chapter 13.
By Player:
Abbvie
Pfizer
Janssen
Amgen
Eli-lilly
Celgene
By Type:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
By End-User:
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Psoriatic Arthritis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Psoriatic Arthritis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Psoriatic Arthritis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Psoriatic Arthritis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Psoriatic Arthritis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Psoriatic Arthritis Drugs Consumption (2017-2022)
-
7.2 United States Psoriatic Arthritis Drugs Consumption (2017-2022)
-
7.3 Europe Psoriatic Arthritis Drugs Consumption (2017-2022)
-
7.4 China Psoriatic Arthritis Drugs Consumption (2017-2022)
-
7.5 Japan Psoriatic Arthritis Drugs Consumption (2017-2022)
-
7.6 India Psoriatic Arthritis Drugs Consumption (2017-2022)
-
7.7 South Korea Psoriatic Arthritis Drugs Consumption (2017-2022)
8 Region and Country-wise Psoriatic Arthritis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
-
8.4 China Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
-
8.6 India Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Psoriatic Arthritis Drugs Consumption Forecast (2022-2028)
9 Global Psoriatic Arthritis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriatic Arthritis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriatic Arthritis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mild Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderate Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Severe Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
10 Global Psoriatic Arthritis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mild Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderate Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Severe Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
11 Global Psoriatic Arthritis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Psoriatic Arthritis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Psoriatic Arthritis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Psoriatic Arthritis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Psoriatic Arthritis Drugs Market Competitive Analysis
-
14.1 Abbvie
-
14.1.1 Abbvie Company Details
-
14.1.2 Abbvie Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbvie Psoriatic Arthritis Drugs Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Psoriatic Arthritis Drugs Product and Service
-
14.3 Janssen
-
14.3.1 Janssen Company Details
-
14.3.2 Janssen Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Janssen Psoriatic Arthritis Drugs Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Psoriatic Arthritis Drugs Product and Service
-
14.5 Eli-lilly
-
14.5.1 Eli-lilly Company Details
-
14.5.2 Eli-lilly Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli-lilly Psoriatic Arthritis Drugs Product and Service
-
14.6 Celgene
-
14.6.1 Celgene Company Details
-
14.6.2 Celgene Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Psoriatic Arthritis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Psoriatic Arthritis Drugs
-
Figure Psoriatic Arthritis Drugs Picture
-
Table Global Psoriatic Arthritis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriatic Arthritis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriatic Arthritis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Psoriatic Arthritis Drugs Consumption by Country (2017-2022)
-
Figure United States Psoriatic Arthritis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriatic Arthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Psoriatic Arthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriatic Arthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Psoriatic Arthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriatic Arthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriatic Arthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Mild Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mild Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Severe Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Psoriatic Arthritis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Psoriatic Arthritis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Psoriatic Arthritis Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Psoriatic Arthritis Drugs Product and Service
-
Table Janssen (Foundation Year, Company Profile and etc.)
-
Table Janssen Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Psoriatic Arthritis Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Psoriatic Arthritis Drugs Product and Service
-
Table Eli-lilly (Foundation Year, Company Profile and etc.)
-
Table Eli-lilly Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli-lilly Psoriatic Arthritis Drugs Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Psoriatic Arthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Psoriatic Arthritis Drugs Product and Service
-
